The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on neuroblastoma cell lines
- 1 November 2001
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 62 (8) , 1099-1105
- https://doi.org/10.1016/s0006-2952(01)00756-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemiaEuropean Journal Of Cancer, 2000
- Molecular Biology of NeuroblastomaJournal of Clinical Oncology, 1999
- MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.Journal of Clinical Oncology, 1997
- Evidence for transformation‐related increase in CTP synthetase activity in situ in human lymphoblastic leukemiaEuropean Journal of Biochemistry, 1993
- Neuroblastoma: Effect of genetic factors on prognosis and treatmentCancer, 1992
- Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetaseBiochemical Pharmacology, 1991
- Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1991
- Cyclopentenylcytosine TriphosphateJournal of Biological Chemistry, 1989
- Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitroAntimicrobial Agents and Chemotherapy, 1988
- Imbalance in the ribonucleotide pools of lymphoid cells from acute lymphoblastic leukemia patientsLeukemia Research, 1986